Uterine Cervical Cancer Clinical Trial
Official title:
Stage IB2 to IVA Uterine Cervical Cancer: Phase 2 Study to Assess a New Therapeutic Sequence Associating a Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine
The scope of the trial is to assess the efficacy of the association gemcitabine-cisplatin + radiotherapy followed by an adjuvant chemotherapy
n/a
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01234480 -
Intended Use Study of the BD SurePath Plus™ Pap
|
||
| Completed |
NCT05022511 -
Three Birds With One Stone
|
N/A | |
| Recruiting |
NCT04857528 -
Detecting HPV DNA in Anal and Cervical Cancers
|
||
| Completed |
NCT01755897 -
A Multicenter, Prospective, Randomized Trial of Adjuvant Chemotherapy for Early-Stage Cervical Cancer Patients
|
N/A | |
| Recruiting |
NCT01667211 -
Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01226264 -
Diffusion MRI; Predictive Value for Cervical Uterine Cancer Recurrence
|
N/A | |
| Recruiting |
NCT03961191 -
DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study
|
||
| Enrolling by invitation |
NCT01393470 -
Evaluation of Long-term HPV Vaccine Efficacy
|
N/A | |
| Terminated |
NCT01284348 -
To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer
|
Phase 2 | |
| Recruiting |
NCT03961178 -
A Cohort Study for the Following up of Conization
|
||
| Terminated |
NCT02317302 -
FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer
|
Phase 1 | |
| Not yet recruiting |
NCT06254846 -
Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study).
|
N/A | |
| Not yet recruiting |
NCT05824494 -
Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors
|
Phase 2 | |
| Completed |
NCT00184093 -
Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03960879 -
DNA Methylation for Screening Uterine Cervical Lesions
|
||
| Recruiting |
NCT04886700 -
Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer
|
Phase 2 | |
| Completed |
NCT02095119 -
A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT05231993 -
Clinical Triage and Treatment of Atypical Glandular Cells (AGC) Detected in Screening
|
N/A | |
| Recruiting |
NCT02036164 -
Adjuvant Chemotherapy for Locally Advanced Cervical Cancer
|
Phase 3 | |
| Recruiting |
NCT04974424 -
Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV
|